-
1
-
-
84955586000
-
Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting
-
Newman, L., et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS ONE 10, e0143304 (2015).
-
(2015)
PLoS ONE
, vol.10
, pp. e0143304
-
-
Newman, L.1
-
2
-
-
84991699153
-
2016 European guideline on Mycoplasma genitalium infections
-
Jensen, J. S., Cusini, M., Gomberg, M., Moi, H. 2016 European guideline on Mycoplasma genitalium infections. J. Eur. Acad. Dermatol. Venereol. 30, 1650-1656 (2016).
-
(2016)
J. Eur. Acad. Dermatol. Venereol.
, vol.30
, pp. 1650-1656
-
-
Jensen, J.S.1
Cusini, M.2
Gomberg, M.3
Moi, H.4
-
3
-
-
79960130072
-
Mycoplasma genitalium: From Chrysalis to multicolored butterfly
-
Taylor-Robinson, D., Jensen, J. S. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin. Microbiol. Rev. 24, 498-514 (2011).
-
(2011)
Clin. Microbiol. Rev.
, vol.24
, pp. 498-514
-
-
Taylor-Robinson, D.1
Jensen, J.S.2
-
5
-
-
84903598016
-
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st Century: Past, evolution, and future
-
Unemo, M., Shafer, W. M. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st Century: past, evolution, and future. Clin. Microbiol. Rev. 27, 587-613 (2014).
-
(2014)
Clin. Microbiol. Rev.
, vol.27
, pp. 587-613
-
-
Unemo, M.1
Shafer, W.M.2
-
6
-
-
84870891391
-
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea
-
Unemo, M., Nicholas, R. A. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 7, 1401-1422 (2012).
-
(2012)
Future Microbiol.
, vol.7
, pp. 1401-1422
-
-
Unemo, M.1
Nicholas, R.A.2
-
7
-
-
84939529739
-
Current and future antimicrobial treatment of gonorrhoea-the rapidly evolving Neisseria gonorrhoeae continues to challenge
-
Unemo, M. Current and future antimicrobial treatment of gonorrhoea-the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect. Dis. 15, 364 (2015).
-
(2015)
BMC Infect. Dis.
, vol.15
, pp. 364
-
-
Unemo, M.1
-
8
-
-
84891847324
-
Current and future treatment options for gonorrhoea
-
Ison, C. A., Deal, C., Unemo, M. Current and future treatment options for gonorrhoea. Sex. Transm. Infect. 89 (Suppl. 4), iv52-iv56 (2013).
-
(2013)
Sex. Transm. Infect.
, vol.89
, pp. iv52-iv56
-
-
Ison, C.A.1
Deal, C.2
Unemo, M.3
-
9
-
-
84879495636
-
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults
-
Bignell, C., Unemo, M. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int. J. STD AIDS 24, 85-92 (2013).
-
(2013)
Int. J. STD AIDS
, vol.24
, pp. 85-92
-
-
Bignell, C.1
Unemo, M.2
-
10
-
-
84930940449
-
Sexually transmitted diseases treatment guidelines 2015
-
Workowski, K. A., Bolan, G. A. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm. Rep. 64, 1-137 (2015).
-
(2015)
MMWR Recomm. Rep.
, vol.64
, pp. 1-137
-
-
Workowski, K.A.1
Bolan, G.A.2
-
11
-
-
34249869095
-
-
Public Health Agency of Canada Gonococcal Infections Chapter (Public Health Agency of Canada
-
Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections. Gonococcal Infections Chapter (Public Health Agency of Canada, 2013).
-
(2013)
Canadian Guidelines on Sexually Transmitted Infections
-
-
-
12
-
-
85014504010
-
-
Australasian Sexual Health Alliance ASHA
-
Australasian Sexual Health Alliance. Australian STI management guidelines for use in primary care. ASHA www. sti. guidelines. org. au/sexually-transmissible-infections/gonorrhoea#management (2016).
-
(2016)
Australian STI Management Guidelines for Use in Primary Care
-
-
-
13
-
-
84875044557
-
Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: A randomized controlled trial
-
Manhart, L. E., et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin. Infect. Dis. 56, 934-942 (2013).
-
(2013)
Clin. Infect. Dis.
, vol.56
, pp. 934-942
-
-
Manhart, L.E.1
-
14
-
-
66949160421
-
A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men
-
Mena, L. A., Mroczkowski, T. F., Nsuami, M., Martin, D. H. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin. Infect. Dis. 48, 1649-1654 (2009).
-
(2009)
Clin. Infect. Dis.
, vol.48
, pp. 1649-1654
-
-
Mena, L.A.1
Mroczkowski, T.F.2
Nsuami, M.3
Martin, D.H.4
-
15
-
-
84901053865
-
Mycoplasma genitalium testing pattern and macrolide resistance: A Danish nationwide retrospective survey
-
Salado-Rasmussen, K., Jensen, J. S. Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. Clin. Infect. Dis. 59, 24-30 (2014).
-
(2014)
Clin. Infect. Dis.
, vol.59
, pp. 24-30
-
-
Salado-Rasmussen, K.1
Jensen, J.S.2
-
16
-
-
84875974965
-
Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic
-
Anagrius, C., Lore, B., Jensen, J. S. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS ONE 8, e61481 (2013).
-
(2013)
PLoS ONE
, vol.8
, pp. e61481
-
-
Anagrius, C.1
Lore, B.2
Jensen, J.S.3
-
17
-
-
79951848615
-
Re-evaluating the treatment of nongonococcal urethritis: Emphasizing emerging pathogens-a randomized clinical trial
-
Schwebke, J. R., et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens-a randomized clinical trial. Clin. Infect. Dis. 52, 163-170 (2011).
-
(2011)
Clin. Infect. Dis.
, vol.52
, pp. 163-170
-
-
Schwebke, J.R.1
-
18
-
-
53549126639
-
Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: An open study
-
Jernberg, E., Moghaddam, A., Moi, H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int. J. STD AIDS 19, 676-679 (2008).
-
(2008)
Int. J. STD AIDS
, vol.19
, pp. 676-679
-
-
Jernberg, E.1
Moghaddam, A.2
Moi, H.3
-
19
-
-
84887372872
-
Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance
-
Couldwell, D. L., Tagg, K. A., Jeoffreys, N. J., Gilbert, G. L. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int. J. STD AIDS 24, 822-828 (2013).
-
(2013)
Int. J. STD AIDS
, vol.24
, pp. 822-828
-
-
Couldwell, D.L.1
Tagg, K.A.2
Jeoffreys, N.J.3
Gilbert, G.L.4
-
20
-
-
84891830853
-
Treatment outcomes for persistent Mycoplasma genitalium associated NGU: Evidence of moxifloxacin treatment failures [abstract O02. 3]
-
Manhart, L. E., et al. Treatment outcomes for persistent Mycoplasma genitalium associated NGU: evidence of moxifloxacin treatment failures [abstract O02. 3]. Sex. Transm. Infect. 89 (Suppl. 1), A29 (2013).
-
(2013)
Sex. Transm. Infect.
, vol.89
, pp. A29
-
-
Manhart, L.E.1
-
21
-
-
84971401923
-
Background review for the '2015 European guideline on the management of Chlamydia trachomatis infections
-
0956462415618838
-
Lanjouw, E., et al. Background review for the '2015 European guideline on the management of Chlamydia trachomatis infections'. Int. J. STD AIDS 2015, 0956462415618838 (2015).
-
(2015)
Int. J. STD AIDS
, vol.2015
-
-
Lanjouw, E.1
-
22
-
-
84958172231
-
2015 UK national guideline for the management of infection with Chlamydia trachomatis
-
Nwokolo, N. C., et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int. J. STD AIDS 27, 251-267 (2016).
-
(2016)
Int. J. STD AIDS
, vol.27
, pp. 251-267
-
-
Nwokolo, N.C.1
-
23
-
-
84860342659
-
Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: Duration of therapy may be the key to improving efficacy
-
Horner, P. J. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. Sex. Transm. Infect. 88, 154-156 (2012).
-
(2012)
Sex. Transm. Infect.
, vol.88
, pp. 154-156
-
-
Horner, P.J.1
-
24
-
-
77957555426
-
Antibiotic resistance in Chlamydiae
-
Sandoz, K. M., Rockey, D. D. Antibiotic resistance in Chlamydiae. Future Microbiol. 5, 1427-1442 (2010).
-
(2010)
Future Microbiol.
, vol.5
, pp. 1427-1442
-
-
Sandoz, K.M.1
Rockey, D.D.2
-
25
-
-
14844320488
-
Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: A meeting report
-
Wang, S. A., et al. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J. Infect. Dis. 191, 917-923 (2005).
-
(2005)
J. Infect. Dis.
, vol.191
, pp. 917-923
-
-
Wang, S.A.1
-
26
-
-
84875700825
-
Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: Whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes
-
O'Neill, C. E., et al. Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes. Microbiology 159, 748-756 (2013).
-
(2013)
Microbiology
, vol.159
, pp. 748-756
-
-
O'Neill, C.E.1
-
27
-
-
80054115542
-
Questioning azithromycin for chlamydial infection
-
Handsfield, H. H. Questioning azithromycin for chlamydial infection. Sex. Transm. Dis. 38, 1028-1029 (2011).
-
(2011)
Sex. Transm. Dis.
, vol.38
, pp. 1028-1029
-
-
Handsfield, H.H.1
-
28
-
-
84863896789
-
Chlamydia trachomatis Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: Predictors and persistence after therapy
-
Sena, A. C., et al. Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J. Infect. Dis. 206, 357-365 (2012).
-
(2012)
J. Infect. Dis.
, vol.206
, pp. 357-365
-
-
Sena, A.C.1
-
29
-
-
84938092817
-
Treatment challenges for urogenital and anorectal Chlamydia trachomatis
-
Kong, F. Y., Hocking, J. S. Treatment challenges for urogenital and anorectal Chlamydia trachomatis. BMC Infect. Dis. 15, 293 (2015).
-
(2015)
BMC Infect. Dis.
, vol.15
, pp. 293
-
-
Kong, F.Y.1
Hocking, J.S.2
-
30
-
-
0034105041
-
Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure
-
Somani, J., Bhullar, V. B., Workowski, K. A., Farshy, C. E., Black, C. M. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J. Infect. Dis. 181, 1421-1427 (2000).
-
(2000)
J. Infect. Dis.
, vol.181
, pp. 1421-1427
-
-
Somani, J.1
Bhullar, V.B.2
Workowski, K.A.3
Farshy, C.E.4
Black, C.M.5
-
31
-
-
79959729027
-
Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin
-
Bhengraj, A. R., Srivastava, P., Mittal, A. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin. Int. J. Antimicrob. Agents 38, 178-179 (2011).
-
(2011)
Int. J. Antimicrob. Agents
, vol.38
, pp. 178-179
-
-
Bhengraj, A.R.1
Srivastava, P.2
Mittal, A.3
-
32
-
-
33645980677
-
Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937)
-
Mpiga, P., Ravaoarinoro, M. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937). Int. J. Antimicrob. Agents 27, 316-324 (2006).
-
(2006)
Int. J. Antimicrob. Agents
, vol.27
, pp. 316-324
-
-
Mpiga, P.1
Ravaoarinoro, M.2
-
33
-
-
84932162013
-
The five days azithromycin treatment regimen (500 mg×1, 250 mg×4) used for Mycoplasma genitalium infections also effectively eradicates Chlamydia trachomatis
-
Unemo, M., Endre, K. M. A., Moi, H. The five days azithromycin treatment regimen (500 mg×1, 250 mg×4) used for Mycoplasma genitalium infections also effectively eradicates Chlamydia trachomatis. Acta Derm. Venereol. 95, 730-732 (2015).
-
(2015)
Acta Derm. Venereol.
, vol.95
, pp. 730-732
-
-
Unemo, M.1
Endre, K.M.A.2
Moi, H.3
-
34
-
-
84988418788
-
2016 European guideline on the management of non-gonococcal urethritis
-
Horner, P. J., Blee, K., Falk, L., van der Meijden, W., Moi, H. 2016 European guideline on the management of non-gonococcal urethritis. Int. J. STD AIDS 27, 928-937 (2016).
-
(2016)
Int. J. STD AIDS
, vol.27
, pp. 928-937
-
-
Horner, P.J.1
Blee, K.2
Falk, L.3
Van Der Meijden, W.4
Moi, H.5
-
35
-
-
84911926573
-
2014 European guideline on the management of syphilis
-
Janier, M., et al. 2014 European guideline on the management of syphilis. J. Eur. Acad. Dermatol. Venereol. 28, 1581-1593 (2014).
-
(2014)
J. Eur. Acad. Dermatol. Venereol.
, vol.28
, pp. 1581-1593
-
-
Janier, M.1
-
36
-
-
84929294383
-
Syphilis: Antibiotic treatment and resistance
-
Stamm, L. V. Syphilis: antibiotic treatment and resistance. Epidemiol. Infect. 143, 1567-1574 (2015).
-
(2015)
Epidemiol. Infect.
, vol.143
, pp. 1567-1574
-
-
Stamm, L.V.1
-
37
-
-
84920920228
-
Syphilis testing, typing, and treatment follow-up: A new era for an old disease
-
Tipple, C., Taylor, G. P. Syphilis testing, typing, and treatment follow-up: a new era for an old disease. Curr. Opin. Infect. Dis. 28, 53-60 (2015).
-
(2015)
Curr. Opin. Infect. Dis.
, vol.28
, pp. 53-60
-
-
Tipple, C.1
Taylor, G.P.2
-
38
-
-
84886032505
-
-
(eds Unemo, M., et al. ) WHO
-
Unemo, M., Ison, C. in Laboratory Diagnosis of Sexually Transmitted Infections, Including Human Immunodeficiency Virus (eds Unemo, M., et al. ) 21-53 (WHO, 2013).
-
(2013)
Laboratory Diagnosis of Sexually Transmitted Infections, Including Human Immunodeficiency Virus
, pp. 21-53
-
-
Unemo, M.1
Ison, C.2
-
39
-
-
1642301383
-
False-positive gonorrhea test results with a nucleic acid amplification test: The impact of low prevalence on positive predictive value
-
Katz, A. R., et al. False-positive gonorrhea test results with a nucleic acid amplification test: the impact of low prevalence on positive predictive value. Clin. Infect. Dis. 38, 814-819 (2004).
-
(2004)
Clin. Infect. Dis.
, vol.38
, pp. 814-819
-
-
Katz, A.R.1
-
40
-
-
12244302907
-
Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae
-
Palmer, H. M., Mallinson, H., Wood, R. L., Herring, A. J. Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae. J. Clin. Microbiol. 41, 835-837 (2003).
-
(2003)
J. Clin. Microbiol.
, vol.41
, pp. 835-837
-
-
Palmer, H.M.1
Mallinson, H.2
Wood, R.L.3
Herring, A.J.4
-
41
-
-
80053492077
-
Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species
-
Tabrizi, S. N., et al. Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species. J. Clin. Microbiol. 49, 3610-3615 (2011).
-
(2011)
J. Clin. Microbiol.
, vol.49
, pp. 3610-3615
-
-
Tabrizi, S.N.1
-
42
-
-
32944465964
-
Nucleic acid amplification testing for Neisseria gonorrhoeae: An ongoing challenge
-
Whiley, D. M., Tapsall, J. W., Sloots, T. P. Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. J. Mol. Diagn. 8, 3-15 (2006).
-
(2006)
J. Mol. Diagn.
, vol.8
, pp. 3-15
-
-
Whiley, D.M.1
Tapsall, J.W.2
Sloots, T.P.3
-
43
-
-
84947795754
-
Evaluation of the new BD Max GC real-time PCR assay, analytically and clinically as a supplementary test for the BD ProbeTec GC Qx Amplified DNA Assay, for molecular detection of Neisseria gonorrhoeae
-
Golparian, D., Boräng, S., Sundqvist, M., Unemo, M. Evaluation of the new BD Max GC real-time PCR assay, analytically and clinically as a supplementary test for the BD ProbeTec GC Qx Amplified DNA Assay, for molecular detection of Neisseria gonorrhoeae. J. Clin. Microbiol. 53, 3935-3937 (2015).
-
(2015)
J. Clin. Microbiol.
, vol.53
, pp. 3935-3937
-
-
Golparian, D.1
Boräng, S.2
Sundqvist, M.3
Unemo, M.4
-
44
-
-
33749993594
-
Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: A position paper on behalf of the Public Health Laboratory Network
-
Smith, D. W., Tapsall, J. W., Lum, G. Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network. Commun. Dis. Intell. Q. Rep. 29, 358-365 (2005).
-
(2005)
Commun. Dis. Intell. Q. Rep.
, vol.29
, pp. 358-365
-
-
Smith, D.W.1
Tapsall, J.W.2
Lum, G.3
-
45
-
-
84989946020
-
A comparison of agar dilution with the Calibrated Dichotomous Sensitivity (CDS) and Etest methods for determining the minimum inhibitory concentration of ceftriaxone against Neisseria gonorrhoeae
-
Enriquez, R. P., Goire, N., Kundu, R., Gatus, B. J., Lahra, M. M. A comparison of agar dilution with the Calibrated Dichotomous Sensitivity (CDS) and Etest methods for determining the minimum inhibitory concentration of ceftriaxone against Neisseria gonorrhoeae. Diagn. Microbiol. Infect. Dis. 86, 40-43 (2016).
-
(2016)
Diagn. Microbiol. Infect. Dis.
, vol.86
, pp. 40-43
-
-
Enriquez, R.P.1
Goire, N.2
Kundu, R.3
Gatus, B.J.4
Lahra, M.M.5
-
46
-
-
84952719585
-
Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: When, where, and how to use?
-
Low, N., Unemo, M. Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use? Curr. Opin. Infect. Dis. 29, 45-51 (2016).
-
(2016)
Curr. Opin. Infect. Dis.
, vol.29
, pp. 45-51
-
-
Low, N.1
Unemo, M.2
-
47
-
-
84895423728
-
Molecular diagnostics for gonorrhoea: Implications for antimicrobial resistance and the threat of untreatable gonorrhoea
-
Low, N., Unemo, M., Jensen, J. S., Breuer, J., Stephenson, J. M. Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea. PLoS Med. 11, e1001598 (2014).
-
(2014)
PLoS Med.
, vol.11
, pp. e1001598
-
-
Low, N.1
Unemo, M.2
Jensen, J.S.3
Breuer, J.4
Stephenson, J.M.5
-
48
-
-
84894059217
-
Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance
-
Goire, N., et al. Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance. Nat. Rev. Microbiol. 12, 223-229 (2014).
-
(2014)
Nat. Rev. Microbiol.
, vol.12
, pp. 223-229
-
-
Goire, N.1
-
49
-
-
70350627375
-
Meeting the public health challenge of multidrug-and extensively drug-resistant Neisseria gonorrhoeae
-
Tapsall, J. W., Ndowa, F., Lewis, D. A., Unemo, M. Meeting the public health challenge of multidrug-and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev. Anti. Infect. Ther. 7, 821-834 (2009).
-
(2009)
Expert Rev. Anti. Infect. Ther.
, vol.7
, pp. 821-834
-
-
Tapsall, J.W.1
Ndowa, F.2
Lewis, D.A.3
Unemo, M.4
-
50
-
-
78649801372
-
Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment Norway 2010
-
Unemo, M., Golparian, D., Syversen, G., Vestrheim, D. F., Moi, H. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill. 15, 19721 (2010).
-
(2010)
Euro Surveill.
, vol.15
, pp. 19721
-
-
Unemo, M.1
Golparian, D.2
Syversen, G.3
Vestrheim, D.F.4
Moi, H.5
-
51
-
-
79955441458
-
Gonorrhoea treatment failures to cefixime and azithromycin in England
-
Ison, C. A., Hussey, J., Sankar, K. N., Evans, J., Alexander, S. Gonorrhoea treatment failures to cefixime and azithromycin in England. Euro Surveill. 16, 19833 (2011).
-
(2011)
Euro Surveill.
, vol.16
, pp. 19833
-
-
Ison, C.A.1
Hussey, J.2
Sankar, K.N.3
Evans, J.4
Alexander, S.5
-
52
-
-
80455144975
-
First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria 2011
-
Unemo, M., Golparian, D., Stary, A., Eigentler, A. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill. 16, 19998 (2011).
-
(2011)
Euro Surveill.
, vol.16
, pp. 19998
-
-
Unemo, M.1
Golparian, D.2
Stary, A.3
Eigentler, A.4
-
53
-
-
84857146496
-
High-level cefixime-and ceftriaxone-resistant N. Gonorrhoeae in France: Novel penA mosaic allele in a successful international clone causes treatment failure
-
Unemo, M., et al. High-level cefixime-and ceftriaxone-resistant N. gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob. Agents Chemother. 56, 1273-1280 (2012).
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 1273-1280
-
-
Unemo, M.1
-
54
-
-
84872054118
-
Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto Canada
-
Allen, V. G., et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 309, 163-170 (2013).
-
(2013)
JAMA
, vol.309
, pp. 163-170
-
-
Allen, V.G.1
-
55
-
-
84929883999
-
Gonorrhea treatment failures with oral and injectable expanded spectrum cephalosporin monotherapy versus dual therapy at 4 Canadian sexually transmitted infection clinics 2010-2013
-
Singh, A. E., et al. Gonorrhea treatment failures with oral and injectable expanded spectrum cephalosporin monotherapy versus dual therapy at 4 Canadian sexually transmitted infection clinics, 2010-2013. Sex. Transm. Dis. 42, 331-336 (2015).
-
(2015)
Sex. Transm. Dis.
, vol.42
, pp. 331-336
-
-
Singh, A.E.1
-
56
-
-
84884922548
-
Phenotypic and genetic characterization of the first two cases of extended-spectrum cephalosporin resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure
-
Lewis, D. A., et al. Phenotypic and genetic characterization of the first two cases of extended-spectrum cephalosporin resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J. Antimicrob. Chemother. 68, 1267-1270 (2013).
-
(2013)
J. Antimicrob. Chemother.
, vol.68
, pp. 1267-1270
-
-
Lewis, D.A.1
-
57
-
-
79959189164
-
Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone
-
Ohnishi, M., et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob. Agents Chemother. 55, 3538-3545 (2011).
-
(2011)
Antimicrob. Agents Chemother.
, vol.55
, pp. 3538-3545
-
-
Ohnishi, M.1
-
58
-
-
67650488213
-
Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods
-
Tapsall, J., et al. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J. Med. Microbiol. 58, 683-687 (2009).
-
(2009)
J. Med. Microbiol.
, vol.58
, pp. 683-687
-
-
Tapsall, J.1
-
59
-
-
84891462477
-
Failure of ceftriaxone 500 mg to eradicate pharyngeal gonorrhoea Australia
-
Chen, Y. M., et al. Failure of ceftriaxone 500 mg to eradicate pharyngeal gonorrhoea, Australia. J. Antimicrob. Chemother. 68, 1445-1447 (2013).
-
(2013)
J. Antimicrob. Chemother.
, vol.68
, pp. 1445-1447
-
-
Chen, Y.M.1
-
60
-
-
84886926874
-
One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney Australia
-
Read, P. J., Limnios, E. A., McNulty, A., Whiley, D., Lahra, L. M. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia. Sex. Health 10, 460-462 (2013).
-
(2013)
Sex. Health
, vol.10
, pp. 460-462
-
-
Read, P.J.1
Limnios, E.A.2
McNulty, A.3
Whiley, D.4
Lahra, L.M.5
-
61
-
-
79951640425
-
Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010
-
Unemo, M., Golparian, D., Hestner, A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill. 16, 1-3 (2011).
-
(2011)
Euro Surveill.
, vol.16
, pp. 1-3
-
-
Unemo, M.1
Golparian, D.2
Hestner, A.3
-
62
-
-
85029592986
-
Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014
-
Golparian, D., et al. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014. Euro Surveill. 19, 20862 (2014).
-
(2014)
Euro Surveill.
, vol.19
, pp. 20862
-
-
Golparian, D.1
-
63
-
-
84862838826
-
Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011
-
Unemo, M., Golparian, D., Potoc?nik, M., Jeverica, S. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill. 17, 1-4 (2012).
-
(2012)
Euro Surveill.
, vol.17
, pp. 1-4
-
-
Unemo, M.1
Golparian, D.2
Potocnik, M.3
Jeverica, S.4
-
64
-
-
84864505639
-
Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia Spain
-
Cámara, J., et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J. Antimicrob. Chemother. 67, 1858-1860 (2012).
-
(2012)
J. Antimicrob. Chemother.
, vol.67
, pp. 1858-1860
-
-
Cámara, J.1
-
65
-
-
78449242759
-
Recommended antimicrobial treatment of uncomplicated gonorrhoea in 2009 in 11 East European countries: Implementation of a Neisseria gonorrhoeae antimicrobial susceptibility programme in this region is crucial
-
Unemo, M., Shipitsyna, E., Domeika, M. Recommended antimicrobial treatment of uncomplicated gonorrhoea in 2009 in 11 East European countries: implementation of a Neisseria gonorrhoeae antimicrobial susceptibility programme in this region is crucial. Sex. Transm. Infect. 86, 442-444 (2010).
-
(2010)
Sex. Transm. Infect.
, vol.86
, pp. 442-444
-
-
Unemo, M.1
Shipitsyna, E.2
Domeika, M.3
-
66
-
-
68249126403
-
Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci
-
Tapsall, J. W. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci. Sex. Transm. Infect. 85, 256-258 (2009).
-
(2009)
Sex. Transm. Infect.
, vol.85
, pp. 256-258
-
-
Tapsall, J.W.1
-
67
-
-
84870998337
-
Sexually transmitted infections, diagnosis and treatment guidelines 2011
-
Japanese Society of Sexually Transmitted Infection. Gonococcal infection
-
Japanese Society of Sexually Transmitted Infection. Gonococcal infection. Sexually transmitted infections, diagnosis and treatment guidelines 2011. Jpn J. Sex. Transm. Dis. 22 (Suppl. 1), 52-59 (2011).
-
(2011)
Jpn J. Sex. Transm. Dis.
, vol.22
, pp. 52-59
-
-
-
68
-
-
85013350957
-
Microbiological efficacy and tolerability of a single-dose regimen of 1 g of ceftriaxone in men with gonococcal urethritis
-
Ito, S., et al. Microbiological efficacy and tolerability of a single-dose regimen of 1 g of ceftriaxone in men with gonococcal urethritis. J. Antimicrob. Chemother. 71, 2559-2562 (2016).
-
(2016)
J. Antimicrob. Chemother.
, vol.71
, pp. 2559-2562
-
-
Ito, S.1
-
69
-
-
78449263982
-
The gonococcus fights back: Is this time a knock out?
-
Lewis, D. A. The gonococcus fights back: is this time a knock out? Sex. Transm. Infect. 86, 415-421 (2010).
-
(2010)
Sex. Transm. Infect.
, vol.86
, pp. 415-421
-
-
Lewis, D.A.1
-
70
-
-
85014449782
-
-
Ch. 9 (eds Davies, J. K., Kahler, C. M. ) ( Caister Academic Press
-
Unemo, M., et al. in Pathogenic Neisseria: Genomics, Molecular Biology and Disease Intervention Ch. 9 (eds Davies, J. K., Kahler, C. M. ) (Caister Academic Press, 2014).
-
(2014)
Pathogenic Neisseria: Genomics, Molecular Biology and Disease Intervention
-
-
Unemo, M.1
-
71
-
-
19944429215
-
Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan
-
Ito, M., et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan. Antimicrob. Agents Chemother. 49, 137-143 (2005).
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 137-143
-
-
Ito, M.1
-
72
-
-
84938791537
-
Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance
-
Cole, M. J., et al. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance. BMC Infect. Dis. 15, 321 (2015).
-
(2015)
BMC Infect. Dis.
, vol.15
, pp. 321
-
-
Cole, M.J.1
-
73
-
-
84981318930
-
Neisseria gonorrhoeae antimicrobial susceptibility surveillance-the Gonococcal Isolate Surveillance Project, 27 sites, United States 2014
-
Kirkcaldy, R. D., et al. Neisseria gonorrhoeae antimicrobial susceptibility surveillance-the Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014. MMWR Surveill. Summ. 65, 1-19 (2016).
-
(2016)
MMWR Surveill. Summ.
, vol.65
, pp. 1-19
-
-
Kirkcaldy, R.D.1
-
74
-
-
84982932015
-
An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England
-
Chisholm, S. A., et al. An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England. Sex. Transm. Infect. 92, 365-367 (2016).
-
(2016)
Sex. Transm. Infect.
, vol.92
, pp. 365-367
-
-
Chisholm, S.A.1
-
75
-
-
84964950008
-
Genomic epidemiology and molecular resistance mechanisms of azithromycin resistant Neisseria gonorrhoeae in Canada from 1997 to 2014
-
Demczuk, W., et al. Genomic epidemiology and molecular resistance mechanisms of azithromycin resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. J. Clin. Microbiol. 54, 1304-1313 (2016).
-
(2016)
J. Clin. Microbiol.
, vol.54
, pp. 1304-1313
-
-
Demczuk, W.1
-
76
-
-
84975463539
-
Failure of dual antimicrobial therapy in treatment of gonorrhea
-
Fifer, H., et al. Failure of dual antimicrobial therapy in treatment of gonorrhea. N. Engl. J. Med. 374, 2504-2506 (2016).
-
(2016)
N. Engl. J. Med.
, vol.374
, pp. 2504-2506
-
-
Fifer, H.1
-
77
-
-
84986268624
-
The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea
-
Kirkcaldy, R. D., et al. The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea. Clin. Infect. Dis. 59, 1083-1091 (2014).
-
(2014)
Clin. Infect. Dis.
, vol.59
, pp. 1083-1091
-
-
Kirkcaldy, R.D.1
-
78
-
-
84862583917
-
In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants-ertapenem for treatment of gonorrhea?
-
Unemo, M., et al. In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants-ertapenem for treatment of gonorrhea? Antimicrob. Agents Chemother. 56, 3603-3609 (2012).
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 3603-3609
-
-
Unemo, M.1
-
79
-
-
84903899178
-
Evaluation of the activity of ertapenem against gonococcal isolates exhibiting a range of susceptibilities to cefixime
-
Quaye, N., Cole, M. J., Ison, C. A. Evaluation of the activity of ertapenem against gonococcal isolates exhibiting a range of susceptibilities to cefixime. J. Antimicrob. Chemother. 69, 1568-1571 (2014).
-
(2014)
J. Antimicrob. Chemother.
, vol.69
, pp. 1568-1571
-
-
Quaye, N.1
Cole, M.J.2
Ison, C.A.3
-
80
-
-
84923234000
-
In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates
-
Hauser, C., Hirzberger, L., Unemo, M., Furrer, H., Endimiani, A. In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates. Antimicrob. Agents Chemother. 59, 1605-1611 (2015).
-
(2015)
Antimicrob. Agents Chemother.
, vol.59
, pp. 1605-1611
-
-
Hauser, C.1
Hirzberger, L.2
Unemo, M.3
Furrer, H.4
Endimiani, A.5
-
81
-
-
77649123172
-
Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi 2007
-
Brown, L. B., et al. Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007. Sex. Transm. Dis. 37, 169-172 (2010).
-
(2010)
Sex. Transm. Dis.
, vol.37
, pp. 169-172
-
-
Brown, L.B.1
-
82
-
-
79951520585
-
An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe
-
Chisholm, S. A., et al. An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. J. Antimicrob. Chemother. 66, 592-595 (2011).
-
(2011)
J. Antimicrob. Chemother.
, vol.66
, pp. 592-595
-
-
Chisholm, S.A.1
-
83
-
-
84877265507
-
Effectiveness of gentamicin for gonorrhoea treatment: Systematic review and meta-analysis
-
Dowell, D., Kirkcaldy, R. D. Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis. Sex. Transm. Infect. 89, 142-147 (2013).
-
(2013)
Sex. Transm. Infect.
, vol.89
, pp. 142-147
-
-
Dowell, D.1
Kirkcaldy, R.D.2
-
84
-
-
84928045158
-
The effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: A systematic review
-
Hathorn, E., Dhasmana, D., Duley, L., Ross, J. D. The effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: a systematic review. Syst. Rev. 3, 104 (2014).
-
(2014)
Syst. Rev.
, vol.3
, pp. 104
-
-
Hathorn, E.1
Dhasmana, D.2
Duley, L.3
Ross, J.D.4
-
85
-
-
84957624350
-
New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae
-
Lee, H., Lee, K., Chong, Y. New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae. Expert Rev. Anti. Infect. Ther. 14, 243-256 (2016).
-
(2016)
Expert Rev. Anti. Infect. Ther.
, vol.14
, pp. 243-256
-
-
Lee, H.1
Lee, K.2
Chong, Y.3
-
86
-
-
84860176932
-
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains including those with various high-level antimicrobial resistance-potential treatment option for gonorrhea?
-
Golparian, D., Fernandes, P., Ohnishi, M., Jensen, J. S., Unemo, M. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains including those with various high-level antimicrobial resistance-potential treatment option for gonorrhea? Antimicrob. Agents Chemother. 56, 2739-2742 (2012).
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 2739-2742
-
-
Golparian, D.1
Fernandes, P.2
Ohnishi, M.3
Jensen, J.S.4
Unemo, M.5
-
87
-
-
78649681337
-
Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis
-
Llano-Sotelo, B., et al. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis. Antimicrob. Agents Chemother. 54, 4961-4970 (2010).
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 4961-4970
-
-
Llano-Sotelo, B.1
-
88
-
-
79955542813
-
Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects
-
Still, J. G., et al. Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects. Antimicrob. Agents Chemother. 55, 1997-2003 (2011).
-
(2011)
Antimicrob. Agents Chemother.
, vol.55
, pp. 1997-2003
-
-
Still, J.G.1
-
89
-
-
84942087886
-
A Phase 2 trial of oral solithromycin 1200 mg or 1000 mg as single-dose oral therapy for uncomplicated gonorrhea
-
Hook, E. W. III, et al. A Phase 2 trial of oral solithromycin 1200 mg or 1000 mg as single-dose oral therapy for uncomplicated gonorrhea. Clin. Infect. Dis. 61, 1043-1048 (2015).
-
(2015)
Clin. Infect. Dis.
, vol.61
, pp. 1043-1048
-
-
Hook, E.W.1
-
90
-
-
84906090956
-
High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea
-
Jacobsson, S., et al. High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea. Antimicrob. Agents Chemother. 58, 5585-5588 (2014).
-
(2014)
Antimicrob. Agents Chemother.
, vol.58
, pp. 5585-5588
-
-
Jacobsson, S.1
-
91
-
-
84920148657
-
In vitro antibacterial activity of AZD0914: A new spiropyrimidinetrione DNA Gyrase/Topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-negative, and atypical bacteria
-
Huband, M. D., et al. In vitro antibacterial activity of AZD0914: a new spiropyrimidinetrione DNA Gyrase/Topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-negative, and atypical bacteria. Antimicrob. Agents Chemother. 59, 467-474 (2015).
-
(2015)
Antimicrob. Agents Chemother.
, vol.59
, pp. 467-474
-
-
Huband, M.D.1
-
92
-
-
84940951189
-
High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (also known as AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates in 21 European countries during 2012-2014
-
Unemo, M., et al. High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (also known as AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates in 21 European countries during 2012-2014. Antimicrob. Agents Chemother. 59, 5220-5225 (2015).
-
(2015)
Antimicrob. Agents Chemother.
, vol.59
, pp. 5220-5225
-
-
Unemo, M.1
-
93
-
-
84954123504
-
Genetic resistance determinants, in vitro time-kill curve analysis and pharmacodynamic functions for the novel topoisomerase II inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae
-
Foerster, S., et al. Genetic resistance determinants, in vitro time-kill curve analysis and pharmacodynamic functions for the novel topoisomerase II inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae. Front. Microbiol. 6, 1377 (2015).
-
(2015)
Front. Microbiol.
, vol.6
, pp. 1377
-
-
Foerster, S.1
-
94
-
-
84937047439
-
Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial type II topoisomerases
-
Basarab, G. S., et al. Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial type II topoisomerases. Sci. Rep. 5, 11827 (2015).
-
(2015)
Sci. Rep.
, vol.5
, pp. 11827
-
-
Basarab, G.S.1
-
95
-
-
84923240925
-
Characterization of the novel DNA gyrase inhibitor AZD0914: Low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae
-
Alm, R. A., et al. Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 59, 1478-1486 (2015).
-
(2015)
Antimicrob. Agents Chemother.
, vol.59
, pp. 1478-1486
-
-
Alm, R.A.1
-
96
-
-
84942849082
-
Non-clinical safety profile of a novel gyrase inhibitor for treatment of Neisseria gonorrhoeae infections, poster F-268 [abstract]
-
American Society for Microbiology, Washington, District of Columbia, USA
-
Basarab, G. S., et al. Non-clinical safety profile of a novel gyrase inhibitor for treatment of Neisseria gonorrhoeae infections, poster F-268 [abstract]. 54th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, District of Columbia, USA (2014).
-
(2014)
54th Intersci. Conf. Antimicrob. Agents Chemother
-
-
Basarab, G.S.1
-
97
-
-
85014482348
-
Safety pharmacokinetics of single escalating oral doses of A. Z. D. 0914: A novel spiropyrimidinetrione antibacterial agent, poster F.-267 [abstract]
-
American Society for Microbiology, Washington, District of Columbia, USA
-
Lawrence, K. O'Connor, K., Atuah, K., Matthews, D., Gardner, H. Safety, pharmacokinetics of single escalating oral doses of A. Z. D. 0914: a novel spiropyrimidinetrione antibacterial agent, poster F.-267 [abstract]. 54th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, District of Columbia, USA (2014).
-
(2014)
54th Intersci. Conf. Antimicrob. Agents Chemother
-
-
Lawrence O'Connor, K.K.1
Atuah, K.2
Matthews, D.3
Gardner, H.4
-
98
-
-
84957877111
-
Multidrug-resistant Neisseria gonorrhoeae isolates from Nanjing, China, are sensitive to killing by a novel DNA Gyrase inhibitor, ETX0914 (AZD0914)
-
Su, X. H., et al. Multidrug-resistant Neisseria gonorrhoeae isolates from Nanjing, China, are sensitive to killing by a novel DNA Gyrase inhibitor, ETX0914 (AZD0914). Antimicrob. Agents Chemother. 60, 621-623 (2015).
-
(2015)
Antimicrob. Agents Chemother.
, vol.60
, pp. 621-623
-
-
Su, X.H.1
-
99
-
-
84962251251
-
-
ClinicalTrials. gov
-
US National Library of Medicine. ClinicalTrials. gov https://clinicaltrials. gov/ct2/show/NCT02210325 (2016).
-
(2016)
US National Library of Medicine
-
-
-
100
-
-
85014489108
-
A phase II trial of single-dose oral ETX0914 (AZD0914) for treatment of uncomplicated urogenital gonorrhea [abstract 5B5]
-
Taylor, S. N., et al. A phase II trial of single-dose oral ETX0914 (AZD0914) for treatment of uncomplicated urogenital gonorrhea [abstract 5B5]. 2016 STD Prevention Conference https://cdc. confex. com/cdc/std2016/webprogram/Paper37739. html (2016).
-
(2016)
2016 STD Prevention Conference
-
-
Taylor, S.N.1
-
101
-
-
0019473954
-
A newly discovered mycoplasma in the human urogenital tract
-
Tully, J. G., Taylor-Robinson, D., Cole, R. M., Rose, D. L. A newly discovered mycoplasma in the human urogenital tract. Lancet 1, 1288-1291 (1981).
-
(1981)
Lancet
, vol.1
, pp. 1288-1291
-
-
Tully, J.G.1
Taylor-Robinson, D.2
Cole, R.M.3
Rose, D.L.4
-
102
-
-
0023840861
-
Non-occurrence of Mycoplasma genitalium in clinical specimens
-
Samra, Z., Borin, M., Bukowsky, Y., Lipshitz, Y., Sompolinsky, D. Non-occurrence of Mycoplasma genitalium in clinical specimens. Eur. J. Clin. Microbiol. Infect. Dis. 7, 49-51 (1988).
-
(1988)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.7
, pp. 49-51
-
-
Samra, Z.1
Borin, M.2
Bukowsky, Y.3
Lipshitz, Y.4
Sompolinsky, D.5
-
103
-
-
0030049587
-
Isolation of Mycoplasma genitalium strains from the male urethra
-
Jensen, J. S., Hansen, H. T., Lind, K. Isolation of Mycoplasma genitalium strains from the male urethra. J. Clin. Microbiol. 34, 286-291 (1996).
-
(1996)
J. Clin. Microbiol.
, vol.34
, pp. 286-291
-
-
Jensen, J.S.1
Hansen, H.T.2
Lind, K.3
-
104
-
-
28844450228
-
Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR
-
Hamasuna, R., Osada, Y., Jensen, J. S. Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR. Antimicrob. Agents Chemother. 49, 4993-4998 (2005).
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 4993-4998
-
-
Hamasuna, R.1
Osada, Y.2
Jensen, J.S.3
-
105
-
-
56749097771
-
Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance
-
Jensen, J. S., Bradshaw, C. S., Tabrizi, S. N., Fairley, C. K., Hamasuna, R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin. Infect. Dis. 47, 1546-1553 (2008).
-
(2008)
Clin. Infect. Dis.
, vol.47
, pp. 1546-1553
-
-
Jensen, J.S.1
Bradshaw, C.S.2
Tabrizi, S.N.3
Fairley, C.K.4
Hamasuna, R.5
-
106
-
-
0026067470
-
Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples
-
Jensen, J. S., Uldum, S. A., Søndergård-Andersen, J., Vuust, J., Lind, K. Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples. J. Clin. Microbiol. 29, 46-50 (1991).
-
(1991)
J. Clin. Microbiol.
, vol.29
, pp. 46-50
-
-
Jensen, J.S.1
Uldum, S.A.2
Søndergård-Andersen, J.3
Vuust, J.4
Lind, K.5
-
107
-
-
0026424255
-
Development and evaluation of the polymerase chain reaction to detect Mycoplasma genitalium
-
Palmer, H. M., Gilroy, C. B., Furr, P. M., Taylor-Robinson, D. Development and evaluation of the polymerase chain reaction to detect Mycoplasma genitalium. FEMS Microbiol. Lett. 61, 199-203 (1991).
-
(1991)
FEMS Microbiol. Lett.
, vol.61
, pp. 199-203
-
-
Palmer, H.M.1
Gilroy, C.B.2
Furr, P.M.3
Taylor-Robinson, D.4
-
108
-
-
84900398666
-
Mycoplasma genitalium: A review
-
Daley, G., Russell, D., Tabrizi, S., McBride, J. Mycoplasma genitalium: a review. Int. J. STD AIDS 25, 475-487 (2014).
-
(2014)
Int. J. STD AIDS
, vol.25
, pp. 475-487
-
-
Daley, G.1
Russell, D.2
Tabrizi, S.3
McBride, J.4
-
109
-
-
84938604217
-
Mycoplasma genitalium infection and female reproductive tract disease: A meta-analysis
-
Lis, R., Rowhani-Rahbar, A., Manhart, L. E. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin. Infect. Dis. 61, 418-426 (2015).
-
(2015)
Clin. Infect. Dis.
, vol.61
, pp. 418-426
-
-
Lis, R.1
Rowhani-Rahbar, A.2
Manhart, L.E.3
-
110
-
-
0027234069
-
Mycoplasma genitalium: A cause of male urethritis?
-
Jensen, J. S., et al. Mycoplasma genitalium: a cause of male urethritis? Genitourin. Med. 69, 265-269 (1993).
-
(1993)
Genitourin. Med.
, vol.69
, pp. 265-269
-
-
Jensen, J.S.1
-
111
-
-
0027305503
-
Association of Mycoplasma genitalium with acute non-gonococcal urethritis
-
Horner, P. J., Gilroy, C. B., Thomas, B. J., Naidoo, R. O., Taylor-Robinson, D. Association of Mycoplasma genitalium with acute non-gonococcal urethritis. Lancet 342, 582-585 (1993).
-
(1993)
Lancet
, vol.342
, pp. 582-585
-
-
Horner, P.J.1
Gilroy, C.B.2
Thomas, B.J.3
Naidoo, R.O.4
Taylor-Robinson, D.5
-
112
-
-
4143049181
-
Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis
-
Falk, L., Fredlund, H., Jensen, J. S. Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis. Sex. Transm. Infect. 80, 289-293 (2004).
-
(2004)
Sex. Transm. Infect.
, vol.80
, pp. 289-293
-
-
Falk, L.1
Fredlund, H.2
Jensen, J.S.3
-
113
-
-
0034015547
-
Mycoplasma genitalium in non-gonococcal urethritis-a study in Swedish male STD patients
-
Björnelius, E., Lidbrink, P., Jensen, J. S. Mycoplasma genitalium in non-gonococcal urethritis-a study in Swedish male STD patients. Int. J. STD AIDS 11, 292-296 (2000).
-
(2000)
Int. J. STD AIDS
, vol.11
, pp. 292-296
-
-
Björnelius, E.1
Lidbrink, P.2
Jensen, J.S.3
-
114
-
-
0028223065
-
Mycoplasma genitalium and non-gonococcal urethritis
-
Horner, P. J., Taylor-Robinson, D. Mycoplasma genitalium and non-gonococcal urethritis. Lancet 343, 790-791 (1994).
-
(1994)
Lancet
, vol.343
, pp. 790-791
-
-
Horner, P.J.1
Taylor-Robinson, D.2
-
115
-
-
31044454940
-
Etiologies of nongonococcal urethritis: Bacteria, viruses, and the association with orogenital exposure
-
Bradshaw, C. S., et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J. Infect. Dis. 193, 336-345 (2006).
-
(2006)
J. Infect. Dis.
, vol.193
, pp. 336-345
-
-
Bradshaw, C.S.1
-
116
-
-
33747154784
-
Mycoplasma genitalium: A common cause of persistent urethritis among men treated with doxycycline
-
Wikström, A., Jensen, J. S. Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sex. Transm. Infect. 82, 276-279 (2006).
-
(2006)
Sex. Transm. Infect.
, vol.82
, pp. 276-279
-
-
Wikström, A.1
Jensen, J.S.2
-
117
-
-
84973644358
-
Urethritis-associated pathogens in urine from men with non-gonococcal urethritis: A case-control study
-
Frølund, M., Björnelius, E., Lidbrink, P., Ahrens, P., Jensen, J. S. Urethritis-associated pathogens in urine from men with non-gonococcal urethritis: a case-control study. Acta Derm. Venereol. 96, 689-694 (2016).
-
(2016)
Acta Derm. Venereol.
, vol.96
, pp. 689-694
-
-
Frølund, M.1
Björnelius, E.2
Lidbrink, P.3
Ahrens, P.4
Jensen, J.S.5
-
118
-
-
84939513951
-
Management of Mycoplasma genitalium infections-can we hit a moving target?
-
Jensen, J. S., Bradshaw, C. Management of Mycoplasma genitalium infections-can we hit a moving target? BMC Infect. Dis. 15, 343 (2015).
-
(2015)
BMC Infect. Dis.
, vol.15
, pp. 343
-
-
Jensen, J.S.1
Bradshaw, C.2
-
119
-
-
0037006632
-
Association between Mycoplasma genitalium and acute endometritis
-
Cohen, C. R., et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 359, 765-766 (2002).
-
(2002)
Lancet
, vol.359
, pp. 765-766
-
-
Cohen, C.R.1
-
120
-
-
0037442502
-
Mucopurulent cervicitis and Mycoplasma genitalium
-
Manhart, L. E., et al. Mucopurulent cervicitis and Mycoplasma genitalium. J. Infect. Dis. 187, 650-657 (2003).
-
(2003)
J. Infect. Dis.
, vol.187
, pp. 650-657
-
-
Manhart, L.E.1
-
121
-
-
29144438883
-
Mycoplasma genitalium: Prevalence, clinical significance, and transmission
-
Anagrius, C., Loré, B., Jensen, J. S. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex. Transm. Infect. 81, 458-462 (2005).
-
(2005)
Sex. Transm. Infect.
, vol.81
, pp. 458-462
-
-
Anagrius, C.1
Loré, B.2
Jensen, J.S.3
-
122
-
-
13544271664
-
Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection
-
Falk, L., Fredlund, H., Jensen, J. S. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex. Transm. Infect. 81, 73-78 (2005).
-
(2005)
Sex. Transm. Infect.
, vol.81
, pp. 73-78
-
-
Falk, L.1
Fredlund, H.2
Jensen, J.S.3
-
123
-
-
10844264570
-
Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome
-
Oakeshott, P., et al. Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome. BJOG 111, 1464-1467 (2004).
-
(2004)
BJOG
, vol.111
, pp. 1464-1467
-
-
Oakeshott, P.1
-
124
-
-
84864067900
-
The spread of Mycoplasma genitalium among men who have sex with men
-
Edlund, M., Blaxhult, A., Bratt, G. The spread of Mycoplasma genitalium among men who have sex with men. Int. J. STD AIDS 23, 455-456 (2012).
-
(2012)
Int. J. STD AIDS
, vol.23
, pp. 455-456
-
-
Edlund, M.1
Blaxhult, A.2
Bratt, G.3
-
125
-
-
77449102870
-
The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic
-
Soni, S., et al. The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic. Sex. Transm. Infect. 86, 21-24 (2010).
-
(2010)
Sex. Transm. Infect.
, vol.86
, pp. 21-24
-
-
Soni, S.1
-
126
-
-
79955526112
-
Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women
-
Lillis, R. A., Nsuami, M. J., Myers, L., Martin, D. H. Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women. J. Clin. Microbiol. 49, 1990-1992 (2011).
-
(2011)
J. Clin. Microbiol.
, vol.49
, pp. 1990-1992
-
-
Lillis, R.A.1
Nsuami, M.J.2
Myers, L.3
Martin, D.H.4
-
127
-
-
3342979406
-
Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic
-
Jensen, J. S., Björnelius, E., Dohn, B., Lidbrink, P. Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic. Sex. Transm. Dis. 31, 499-507 (2004).
-
(2004)
Sex. Transm. Dis.
, vol.31
, pp. 499-507
-
-
Jensen, J.S.1
Björnelius, E.2
Dohn, B.3
Lidbrink, P.4
-
128
-
-
84962737609
-
Epidemiology of Mycoplasma genitalium in British men and women aged 16-44 years: Evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)
-
Sonnenberg, P., et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16-44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Int. J. Epidemiol. 44, 1982-1994 (2015).
-
(2015)
Int. J. Epidemiol.
, vol.44
, pp. 1982-1994
-
-
Sonnenberg, P.1
-
129
-
-
33947200740
-
Isolation of Mycoplasma genitalium from first-void urine specimens by coculture with Vero cells
-
Hamasuna, R., Osada, Y., Jensen, J. S. Isolation of Mycoplasma genitalium from first-void urine specimens by coculture with Vero cells. J. Clin. Microbiol. 45, 847-850 (2007).
-
(2007)
J. Clin. Microbiol.
, vol.45
, pp. 847-850
-
-
Hamasuna, R.1
Osada, Y.2
Jensen, J.S.3
-
130
-
-
84979539460
-
Evaluation of the Hologic Panther transcription mediated amplification assay for detection of Mycoplasma genitalium
-
Tabrizi, S. N., et al. Evaluation of the Hologic Panther transcription mediated amplification assay for detection of Mycoplasma genitalium. J. Clin. Microbiol. 54, 2201-2203 (2016).
-
(2016)
J. Clin. Microbiol.
, vol.54
, pp. 2201-2203
-
-
Tabrizi, S.N.1
-
131
-
-
0033829110
-
The biology of Mycoplasma genitalium
-
Taylor-Robinson, D., Gilroy, C. B., Jensen, J. S. The biology of Mycoplasma genitalium. Venereology 13, 119-127 (2000).
-
(2000)
Venereology
, vol.13
, pp. 119-127
-
-
Taylor-Robinson, D.1
Gilroy, C.B.2
Jensen, J.S.3
-
132
-
-
70350331088
-
Antimicrobial susceptibilities of Mycoplasma genitalium by broth dilution and quantitative PCR
-
Hamasuna, R., Jensen, J. S., Osada, Y. Antimicrobial susceptibilities of Mycoplasma genitalium by broth dilution and quantitative PCR. Antimicrob. Agents Chemother. 53, 4938-4939 (2009).
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 4938-4939
-
-
Hamasuna, R.1
Jensen, J.S.2
Osada, Y.3
-
133
-
-
84901053866
-
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and-susceptible Mycoplasma genitalium strains
-
Jensen, J. S., Fernandes, P., Unemo, M. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and-susceptible Mycoplasma genitalium strains. Antimicrob. Agents Chemother. 58, 3151-3156 (2014).
-
(2014)
Antimicrob. Agents Chemother.
, vol.58
, pp. 3151-3156
-
-
Jensen, J.S.1
Fernandes, P.2
Unemo, M.3
-
134
-
-
84867564077
-
Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae Mycoplasma hominis, and Ureaplasma urealyticum
-
Waites, K. B., et al. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. J. Clin. Microbiol. 50, 3542-3547 (2012).
-
(2012)
J. Clin. Microbiol.
, vol.50
, pp. 3542-3547
-
-
Waites, K.B.1
-
135
-
-
33745949316
-
Azithromycin failure in Mycoplasma genitalium urethritis
-
Bradshaw, C. S., et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg. Infect. Dis. 12, 1149-1152 (2006).
-
(2006)
Emerg. Infect. Dis.
, vol.12
, pp. 1149-1152
-
-
Bradshaw, C.S.1
-
136
-
-
0026538607
-
In-vitro susceptibilities of Mycoplasma genitalium to antibiotics
-
Renaudin, H., Tully, J. G., Bebear, C. In-vitro susceptibilities of Mycoplasma genitalium to antibiotics. Antimicrob. Agents Chemother. 36, 870-872 (1992).
-
(1992)
Antimicrob. Agents Chemother.
, vol.36
, pp. 870-872
-
-
Renaudin, H.1
Tully, J.G.2
Bebear, C.3
-
137
-
-
0031725507
-
Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro
-
Hannan, P. C. Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro. J. Med. Microbiol. 47, 1115-1122 (1998).
-
(1998)
J. Med. Microbiol.
, vol.47
, pp. 1115-1122
-
-
Hannan, P.C.1
-
138
-
-
84860000290
-
Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis
-
Twin, J., et al. Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. PLoS ONE 7, e35593 (2012).
-
(2012)
PLoS ONE
, vol.7
, pp. e35593
-
-
Twin, J.1
-
139
-
-
84864839208
-
-
eds MacKenzie, C. R., Henrich, B. Humana Press
-
Jensen, J. S. in Diagnosis of Sexually Transmitted Diseases: Methods and Protocols (eds MacKenzie, C. R., Henrich, B. ) 129-139 (Humana Press, 2012).
-
(2012)
Diagnosis of Sexually Transmitted Diseases: Methods and Protocols
, pp. 129-139
-
-
Jensen, J.S.1
-
140
-
-
84899540393
-
Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis
-
Touati, A., Peuchant, O., Jensen, J. S., Bebear, C., Pereyre, S. Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis. J. Clin. Microbiol. 52, 1549-1555 (2014).
-
(2014)
J. Clin. Microbiol.
, vol.52
, pp. 1549-1555
-
-
Touati, A.1
Peuchant, O.2
Jensen, J.S.3
Bebear, C.4
Pereyre, S.5
-
141
-
-
84948718569
-
Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR
-
Wold, C., et al. Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR. J. Eur. Acad. Dermatol. Venereol. 29, 1616-1620 (2015).
-
(2015)
J. Eur. Acad. Dermatol. Venereol.
, vol.29
, pp. 1616-1620
-
-
Wold, C.1
-
142
-
-
84974725329
-
Multiplex assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance using PlexZyme and PlexPrime technology
-
Tabrizi, S. N., et al. Multiplex assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance using PlexZyme and PlexPrime technology. PLoS ONE 11, e0156740 (2016).
-
(2016)
PLoS ONE
, vol.11
, pp. e0156740
-
-
Tabrizi, S.N.1
-
143
-
-
85014458799
-
Multiplex real-time PCR assay targeting macrolide resistance mutations in Mycoplasma genitalium [abstract P0926]
-
Thellin, O., et al. Multiplex real-time PCR assay targeting macrolide resistance mutations in Mycoplasma genitalium [abstract P0926]. 26th European Congress of Clinical Microbiology and Infectious Diseases https://www. escmid. org/escmid-publications/escmid-elibrary/?q=thellin&id= 2173&L=0&x=0&y=0 (2016).
-
(2016)
26th European Congress of Clinical Microbiology and Infectious Diseases
-
-
Thellin, O.1
-
144
-
-
0035184291
-
Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment
-
Deguchi, T., et al. Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment. J. Antimicrob. Chemother. 48, 742-744 (2001).
-
(2001)
J. Antimicrob. Chemother.
, vol.48
, pp. 742-744
-
-
Deguchi, T.1
-
145
-
-
85014494730
-
Simultaneous detection of Mycoplasma genitalium and key mutations conferring resistance to fluoroquinolone antibiotics using a novel real-time QPCR technology [abstract S5]
-
Walker, S., et al. Simultaneous detection of Mycoplasma genitalium and key mutations conferring resistance to fluoroquinolone antibiotics using a novel real-time QPCR technology [abstract S5]. 21st Congress of the International Organization for Mycoplasmology (2016).
-
(2016)
21st Congress of the International Organization for Mycoplasmology
-
-
Walker, S.1
-
146
-
-
84894247045
-
High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: The need for routine testing and the inadequacy of current treatment options
-
Pond, M. J., et al. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. Clin. Infect. Dis. 58, 631-637 (2014).
-
(2014)
Clin. Infect. Dis.
, vol.58
, pp. 631-637
-
-
Pond, M.J.1
-
147
-
-
84905979525
-
Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan
-
Kikuchi, M., et al. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. J. Antimicrob. Chemother. 69, 2376-2382 (2014).
-
(2014)
J. Antimicrob. Chemother.
, vol.69
, pp. 2376-2382
-
-
Kikuchi, M.1
-
148
-
-
77954958494
-
Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance
-
Shimada, Y., et al. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance. Int. J. Antimicrob. Agents 36, 255-258 (2010).
-
(2010)
Int. J. Antimicrob. Agents
, vol.36
, pp. 255-258
-
-
Shimada, Y.1
-
149
-
-
0026778726
-
A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis
-
Martin, D. H., et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N. Engl. J. Med. 327, 921-925 (1992).
-
(1992)
N. Engl. J. Med.
, vol.327
, pp. 921-925
-
-
Martin, D.H.1
-
150
-
-
84891835202
-
Time to manage Mycoplasma genitalium as an STI: But not with azithromycin 1 g
-
Horner, P., Blee, K., Adams, E. Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! Curr. Opin. Infect. Dis. 27, 68-74 (2014).
-
(2014)
Curr. Opin. Infect. Dis.
, vol.27
, pp. 68-74
-
-
Horner, P.1
Blee, K.2
Adams, E.3
-
151
-
-
38849199660
-
Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: A controlled clinical trial
-
Björnelius, E., et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex. Transm. Infect. 84, 72-76 (2008).
-
(2008)
Sex. Transm. Infect.
, vol.84
, pp. 72-76
-
-
Björnelius, E.1
-
152
-
-
84950256469
-
Efficacy of antimicrobial therapy for Mycoplasma genitalium infections
-
Manhart, L. E., Jensen, J. S., Bradshaw, C. S., Golden, M. R., Martin, D. H. Efficacy of antimicrobial therapy for Mycoplasma genitalium infections. Clin. Infect. Dis. 61 (Suppl. 8), S802-S817 (2015).
-
(2015)
Clin. Infect. Dis.
, vol.61
, pp. S802-S817
-
-
Manhart, L.E.1
Jensen, J.S.2
Bradshaw, C.S.3
Golden, M.R.4
Martin, D.H.5
-
153
-
-
84860324649
-
Mycoplasma genitalium presence, resistance and epidemiology in Greenland
-
Gesink, D. C., et al. Mycoplasma genitalium presence, resistance and epidemiology in Greenland. Int. J. Circumpolar Health 71, 1-8 (2012).
-
(2012)
Int. J. Circumpolar Health
, vol.71
, pp. 1-8
-
-
Gesink, D.C.1
-
154
-
-
84924045162
-
Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin
-
Guschin, A., Ryzhikh, P., Rumyantseva, T., Gomberg, M., Unemo, M. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin. BMC Infect. Dis. 15, 40 (2015).
-
(2015)
BMC Infect. Dis.
, vol.15
, pp. 40
-
-
Guschin, A.1
Ryzhikh, P.2
Rumyantseva, T.3
Gomberg, M.4
Unemo, M.5
-
155
-
-
0942279624
-
In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae
-
Pereyre, S., et al. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 48, 460-465 (2004).
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 460-465
-
-
Pereyre, S.1
-
156
-
-
0034096392
-
Occurrence and treatment of Mycoplasma genitalium in patients visiting STD clinics in Sweden
-
Johannisson, G., et al. Occurrence and treatment of Mycoplasma genitalium in patients visiting STD clinics in Sweden. Int. J. STD AIDS 11, 324-326 (2000).
-
(2000)
Int. J. STD AIDS
, vol.11
, pp. 324-326
-
-
Johannisson, G.1
-
157
-
-
0034897185
-
Association of Mycoplasma genitalium persistence in the urethra with recurrence of nongonococcal urethritis
-
Maeda, S. I., et al. Association of Mycoplasma genitalium persistence in the urethra with recurrence of nongonococcal urethritis. Sex. Transm. Dis. 28, 472-476 (2001).
-
(2001)
Sex. Transm. Dis.
, vol.28
, pp. 472-476
-
-
Maeda, S.I.1
-
158
-
-
27444446953
-
In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of M. Genitalium-positive nongonococcal urethritis in men
-
Yasuda, M., Maeda, S., Deguchi, T. In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of M. genitalium-positive nongonococcal urethritis in men. Clin. Infect. Dis. 41, 1357-1359 (2005).
-
(2005)
Clin. Infect. Dis.
, vol.41
, pp. 1357-1359
-
-
Yasuda, M.1
Maeda, S.2
Deguchi, T.3
-
159
-
-
80051592408
-
Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis
-
Takahashi, S., et al. Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. J. Infect. Chemother. 17, 392-396 (2011).
-
(2011)
J. Infect. Chemother.
, vol.17
, pp. 392-396
-
-
Takahashi, S.1
-
160
-
-
84863315906
-
Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium
-
Terada, M., Izumi, K., Ohki, E., Yamagishi, Y., Mikamo, H. Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium. J. Infect. Chemother. 18, 313-317 (2012).
-
(2012)
J. Infect. Chemother.
, vol.18
, pp. 313-317
-
-
Terada, M.1
Izumi, K.2
Ohki, E.3
Yamagishi, Y.4
Mikamo, H.5
-
161
-
-
56149087235
-
Persistence of Mycoplasma genitalium following azithromycin therapy
-
Bradshaw, C. S., Chen, M. Y., Fairley, C. K. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE 3, e3618 (2008).
-
(2008)
PLoS ONE
, vol.3
, pp. e3618
-
-
Bradshaw, C.S.1
Chen, M.Y.2
Fairley, C.K.3
-
162
-
-
84928202016
-
Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: Follow-up of a clinical cohort
-
Gundevia, Z., Foster, R., Jamil, M. S., McNulty, A. Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: follow-up of a clinical cohort. Sex. Transm. Infect. 91, 11-13 (2015).
-
(2015)
Sex. Transm. Infect.
, vol.91
, pp. 11-13
-
-
Gundevia, Z.1
Foster, R.2
Jamil, M.S.3
McNulty, A.4
-
163
-
-
84926639944
-
Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens
-
Bissessor, M., et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin. Infect. Dis. 60, 1228-1236 (2015).
-
(2015)
Clin. Infect. Dis.
, vol.60
, pp. 1228-1236
-
-
Bissessor, M.1
-
164
-
-
84879431312
-
Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium
-
Tagg, K. A., Jeoffreys, N. J., Couldwell, D. L., Donald, J. A., Gilbert, G. L. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium. J. Clin. Microbiol. 51, 2245-2249 (2013).
-
(2013)
J. Clin. Microbiol.
, vol.51
, pp. 2245-2249
-
-
Tagg, K.A.1
Jeoffreys, N.J.2
Couldwell, D.L.3
Donald, J.A.4
Gilbert, G.L.5
-
165
-
-
0042388383
-
Tetracycline treatment does not eradicate Mycoplasma genitalium
-
Falk, L., Fredlund, H., Jensen, J. S. Tetracycline treatment does not eradicate Mycoplasma genitalium. Sex. Transm. Infect. 79, 318-319 (2003).
-
(2003)
Sex. Transm. Infect.
, vol.79
, pp. 318-319
-
-
Falk, L.1
Fredlund, H.2
Jensen, J.S.3
-
166
-
-
84878492596
-
Development of doxycycline MIC and disk diffusion interpretive breakpoints and revision of tetracycline breakpoints for Streptococcus pneumoniae
-
Dallas, S. D., et al. Development of doxycycline MIC and disk diffusion interpretive breakpoints and revision of tetracycline breakpoints for Streptococcus pneumoniae. J. Clin. Microbiol. 51, 1798-1802 (2013).
-
(2013)
J. Clin. Microbiol.
, vol.51
, pp. 1798-1802
-
-
Dallas, S.D.1
-
167
-
-
84863332784
-
Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin
-
Ito, S., et al. Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin. J. Infect. Chemother. 18, 414-418 (2012).
-
(2012)
J. Infect. Chemother.
, vol.18
, pp. 414-418
-
-
Ito, S.1
-
168
-
-
84885948177
-
Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritis
-
Takahashi, S., et al. Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritis. J. Infect. Chemother. 19, 941-945 (2013).
-
(2013)
J. Infect. Chemother.
, vol.19
, pp. 941-945
-
-
Takahashi, S.1
-
169
-
-
84903723836
-
Prediction of the persistence of Mycoplasma genitalium after antimicrobial chemotherapy by quantification of leukocytes in first-void urine from patients with non-gonococcal urethritis
-
Ito, S., et al. Prediction of the persistence of Mycoplasma genitalium after antimicrobial chemotherapy by quantification of leukocytes in first-void urine from patients with non-gonococcal urethritis. J. Infect. Chemother. 20, 298-302 (2014).
-
(2014)
J. Infect. Chemother.
, vol.20
, pp. 298-302
-
-
Ito, S.1
-
170
-
-
84882334233
-
Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010
-
Paukner, S., Sader, H. S., Ivezic-Schoenfeld, Z., Jones, R. N. Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010. Antimicrob. Agents Chemother. 57, 4489-4495 (2013).
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, pp. 4489-4495
-
-
Paukner, S.1
Sader, H.S.2
Ivezic-Schoenfeld, Z.3
Jones, R.N.4
-
171
-
-
84903636221
-
In vitro activity of the novel pleuromutilin BC-3781 tested against bacterial pathogens causing sexually transmitted diseases (STD)
-
Paukner, S., Gruss, A., Fritsche, T. R., Ivezic-Schoenfeld, Z., Jones, R. N. In vitro activity of the novel pleuromutilin BC-3781 tested against bacterial pathogens causing sexually transmitted diseases (STD). Interscience Conference of Antimicrobial Agents and Chemotherapy E-1183 (2014).
-
(2014)
Interscience Conference of Antimicrobial Agents and Chemotherapy E-1183
-
-
Paukner, S.1
Gruss, A.2
Fritsche, T.R.3
Ivezic-Schoenfeld, Z.4
Jones, R.N.5
-
172
-
-
84876239981
-
Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infections
-
Prince, W. T., et al. Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infections. Antimicrob. Agents Chemother. 57, 2087-2094 (2013).
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, pp. 2087-2094
-
-
Prince, W.T.1
-
173
-
-
84929613792
-
In vitro antibacterial activity of AZD0914 against human mycoplasmas and ureaplasmas
-
Waites, K. B., Crabb, D. M., Duffy, L. B., Huband, M. D. In vitro antibacterial activity of AZD0914 against human mycoplasmas and ureaplasmas. Antimicrob. Agents Chemother. 59, 3627-3629 (2015).
-
(2015)
Antimicrob. Agents Chemother.
, vol.59
, pp. 3627-3629
-
-
Waites, K.B.1
Crabb, D.M.2
Duffy, L.B.3
Huband, M.D.4
-
174
-
-
84952056755
-
Azithromycin versus doxycycline for urogenital Chlamydia trachomatis infection
-
Geisler, W. M., et al. Azithromycin versus doxycycline for urogenital Chlamydia trachomatis infection. N. Engl. J. Med. 373, 2512-2521 (2015).
-
(2015)
N. Engl. J. Med.
, vol.373
, pp. 2512-2521
-
-
Geisler, W.M.1
-
175
-
-
84939480246
-
Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women
-
Falk, L., Enger, M., Jensen, J. S. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women. J. Antimicrob. Chemother. 70, 3134-3140 (2015).
-
(2015)
J. Antimicrob. Chemother.
, vol.70
, pp. 3134-3140
-
-
Falk, L.1
Enger, M.2
Jensen, J.S.3
-
176
-
-
84864252012
-
The serious threat of multidrug-resistant and untreatable gonorrhoea: The pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health
-
Ndowa, F., Lusti-Narasimhan, M., Unemo, M. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex. Transm. Infect. 88, 317-318 (2012).
-
(2012)
Sex. Transm. Infect.
, vol.88
, pp. 317-318
-
-
Ndowa, F.1
Lusti-Narasimhan, M.2
Unemo, M.3
-
177
-
-
84930592840
-
Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?
-
Lewis, D. A. Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains? Sex. Transm. Infect. 91, 234-237 (2015).
-
(2015)
Sex. Transm. Infect.
, vol.91
, pp. 234-237
-
-
Lewis, D.A.1
-
178
-
-
84979622689
-
Multiplex real-time PCR with high-resolution melting analysis for the characterization of antimicrobial resistance in Neisseria gonorrhoeae
-
Donà, V., et al. Multiplex real-time PCR with high-resolution melting analysis for the characterization of antimicrobial resistance in Neisseria gonorrhoeae. J. Clin. Microbiol. 54, 2074-2081 (2016).
-
(2016)
J. Clin. Microbiol.
, vol.54
, pp. 2074-2081
-
-
Donà, V.1
|